Comparative Efficacy and Safety of Immunotherapy on Non–Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Network Meta‐Analysis

Documenti analoghi

• A Meta‐Analysis of Efficacy and Safety of Neoadjuvant Immunotherapy Plus Chemotherapy for Resectable Non‐Small Cell Lung Cancer
  di: Xinru Sun, et al.
  Pubblicazione: (2024)
• Survival Outcomes in EGFR‐Mutant Non‐Small Cell Lung Cancer With Brain Metastases: Kaplan–Meier and Cox Regression Analyses Across Treatment Stages
  di: Haoran Qi, et al.
  Pubblicazione: (2025)
• Evaluation of Efficacy and Safety in First‐Line Treatment Methods for Extensive‐Stage Small Cell Lung Cancer: A Comprehensive Comparative Study of Chemotherapy, Targeted Therapy Combined With Chemotherapy, and Immunotherapy Combined With Chemotherapy
  di: Tiantian Zhang, et al.
  Pubblicazione: (2024)
• The Clinical Efficacy and Safety of Nintedanib in the Treatment of Interstitial Lung Disease Among Patients With Systemic Sclerosis: Systematic Review
  di: Khaled S. Al Oweidat, et al.
  Pubblicazione: (2025)
• A Nomogram for Predicting Recurrence in Stage I Non‐Small Cell Lung Cancer
  di: Rongrong Bian, et al.
  Pubblicazione: (2024)